Food Allergy News and Research

Report: 150% Rise in ER Visits for Severe Allergic Reactions Among Children

The Blue Cross Blue Shield Association (BCBSA) released a report called Childhood Allergies in America. The study showed that allergy rates among children increased from 2010 to 2016. The study looked at about 9.6 million U.S. with health insurance, ages 18 and younger. It found that 18 percent of these children have allergies. They looked at anaphylaxis (a severe allergic reaction), dermatitis (inflamed skin or skin rash) and rhinitis (runny, stuffy nose).

Research Suggests Eosinophilic Esophagitis Is a Late Manifestation of the Atopic March

The atopic march describes how patients who have an allergic disease are more likely to develop another or multiple allergic diseases in their lifetime. This progression commonly starts with eczema in infancy and can develop into food allergy, asthma or hay fever in childhood. Now, new research being presented at the Joint Congress provides evidence that EoE is a late but probable part of this disease progression.

Treatment for Milk Allergy Shows Positive Results in Clinical Trial

DBV Technologies today announced preliminary results from Part B, or Phase II, of a Phase I/II study evaluating the efficacy and safety of three dose regimens of Viaskin Milk (150 µg, 300 µg, 500 µg) in 198 patients for the treatment of IgE-mediated cow's milk protein allergy (CMPA). The MILES (Milk Efficacy and Safety) study was designed to determine a safe and effective dose in two age groups.

Two Peanut Allergy Treatment Trials Move Forward

Kids With Food Allergies is sharing these press releases from Aimmune Therapeutics and DBV Technologies to bring you the latest research news quickly. [PRESS RELEASE] Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy BRISBANE, Calif.– (BUSINESS WIRE) – Feb. 20, 2018 – Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced...

KFA Issues Parental Guidance Warning About New Peter Rabbit Film

The Asthma and Allergy Foundation of America (AAFA) cautions parents raising children with food allergies that some scenes in the newly-released “Peter Rabbit” film may be disturbing for young viewers with food allergies. In the film, a character with a known food allergy to blackberries is attacked with them. This leads to a severe allergic reaction known as anaphylaxis and the need to use a lifesaving injection of the drug epinephrine.

Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
8201 Corporate Drive Suite 1000 Landover, MD 20785
Phone: 1-800-7-ASTHMA (1.800.727.8462)